UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

_________________

FORM 8-K
_________________

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report  (Date of earliest event reported):   January 21, 2005

_________________

MICROTEK MEDICAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)

_________________

Georgia	0-24866	58-1746149
(State or Other Jurisdiction       of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

512 Lehmberg Road, Columbus, Mississippi 39702
(Address of principal executive office)  (zip code)

Registrant’s telephone number, including area code:   (662) 327-1863

___________________________________________________
        (Former name or former address, if changed since last report)

_________________

        Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02  Results of Operations and Financial Condition.

On January 21, 2005, Microtek Medical Holdings, Inc. (the “Company”) issued a press release announcing its anticipated net revenues for the quarter ended December 31, 2004. This press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference.

Item 9.01  Financial Statements and Exhibits.

(a) Financial Statements.

N/A

(b) Pro Forma Financial Information.

N/A

(c) Exhibits.

Exhibit Number	Description
99.1	Press release dated January 21, 2005, announcing the Company's anticipated net revenues for the quarter ended December 31, 2004

2

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MICROTEK MEDICAL HOLDINGS, INC.
Date:   January 21, 2005	By:  /s/ Dan R. Lee          Dan R. Lee, Chairman, President and Chief Executive          Officer
	By:  /s/ Roger G. Wilson          Roger G. Wilson, Chief Financial Officer

3

EXHIBIT INDEX

Exhibit Number	Description
99.1	Press release dated January 21, 2005, announcing the Company's anticipated net revenues for the quarter ended December 31, 2004

4